Literature DB >> 24390335

Evolutionarily conserved requirement for core binding factor beta in the assembly of the human immunodeficiency virus/simian immunodeficiency virus Vif-cullin 5-RING E3 ubiquitin ligase.

Xue Han1, Weizi Liang, Deping Hua, Xiaohong Zhou, Juan Du, Sean L Evans, Qimeng Gao, Hong Wang, Rachel Viqueira, Wei Wei, Wenyan Zhang, Xiao-Fang Yu.   

Abstract

UNLABELLED: The human immunodeficiency virus type 1 (HIV-1)-encoded virion infectivity factor (Vif) is required to inactivate the host restriction factor APOBEC3 by engaging Cullin 5 (Cul5)-RING ubiquitin ligase (CRL5). Core binding factor beta (CBF-β) is a novel regulator of Vif-CRL5 function; as yet, its mechanism of regulation remains unclear. In the present study, we demonstrate that CBF-β promotion of Vif-CRL5 assembly is independent of its influence on Vif stability and is also a conserved feature of primate lentiviral Vif proteins. Furthermore, CBF-β is critical for the formation of the Vif-ElonginB/ElonginC-Cul5 core E3 ubiquitin ligase complex in vitro. CBF-β from diverse vertebrate species supported HIV-1 Vif function, indicating the conserved nature of Vif-CBF-β interfaces. Considering the importance of the interaction between Vif and CBF-β in viral CRL5 function, disrupting this interaction represents an attractive pharmacological intervention against HIV-1. IMPORTANCE: HIV-1 encodes virion infectivity factor (Vif) to inactivate its host's antiviral APOBEC3 proteins. Vif triggers APOBEC3 degradation by forming Vif-Cullin 5 (Cul5)-RING ubiquitin ligase (CRL5). Core binding factor beta (CBF-β) is a novel regulator of Vif-CRL5 function whose mechanism of regulation remains poorly defined. In the present study, we demonstrate that the promotion of Vif-CRL5 assembly by CBF-β can be separated from its influence on Vif stability. The promotion of Vif-CRL5 assembly, but not the influence on Vif stability, is conserved among primate lentiviral Vif proteins: we found that CBF-β from diverse vertebrate species supported HIV-1 Vif function. Considering the importance of the interaction between Vif and CBF-β in viral CRL5 function and HIV-1 replication, disrupting this interaction is an attractive strategy against HIV-1.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24390335      PMCID: PMC3957933          DOI: 10.1128/JVI.03833-13

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  51 in total

1.  Induction of APOBEC3G ubiquitination and degradation by an HIV-1 Vif-Cul5-SCF complex.

Authors:  Xianghui Yu; Yunkai Yu; Bindong Liu; Kun Luo; Wei Kong; Panyong Mao; Xiao-Fang Yu
Journal:  Science       Date:  2003-10-16       Impact factor: 47.728

2.  A novel DCAF1-binding motif required for Vpx-mediated degradation of nuclear SAMHD1 and Vpr-induced G2 arrest.

Authors:  Wei Wei; Haoran Guo; Xue Han; Xianjun Liu; Xiaohong Zhou; Wenyan Zhang; Xiao-Fang Yu
Journal:  Cell Microbiol       Date:  2012-08-09       Impact factor: 3.715

3.  Phosphorylation of a novel SOCS-box regulates assembly of the HIV-1 Vif-Cul5 complex that promotes APOBEC3G degradation.

Authors:  Andrew Mehle; Joao Goncalves; Mariana Santa-Marta; Mark McPike; Dana Gabuzda
Journal:  Genes Dev       Date:  2004-12-01       Impact factor: 11.361

Review 4.  Intrinsic immunity: a front-line defense against viral attack.

Authors:  Paul D Bieniasz
Journal:  Nat Immunol       Date:  2004-11       Impact factor: 25.606

5.  Primate lentiviral virion infectivity factors are substrate receptors that assemble with cullin 5-E3 ligase through a HCCH motif to suppress APOBEC3G.

Authors:  Kun Luo; Zuoxiang Xiao; Elana Ehrlich; Yunkai Yu; Bindong Liu; Shu Zheng; Xiao-Fang Yu
Journal:  Proc Natl Acad Sci U S A       Date:  2005-08-02       Impact factor: 11.205

6.  APOBEC4, a new member of the AID/APOBEC family of polynucleotide (deoxy)cytidine deaminases predicted by computational analysis.

Authors:  Igor B Rogozin; Malay K Basu; I King Jordan; Youri I Pavlov; Eugene V Koonin
Journal:  Cell Cycle       Date:  2005-09-06       Impact factor: 4.534

7.  Vif proteins of human and simian immunodeficiency viruses require cellular CBFβ to degrade APOBEC3 restriction factors.

Authors:  Judd F Hultquist; Mawuena Binka; Rebecca S LaRue; Viviana Simon; Reuben S Harris
Journal:  J Virol       Date:  2011-12-28       Impact factor: 5.103

8.  Mutational alteration of human immunodeficiency virus type 1 Vif allows for functional interaction with nonhuman primate APOBEC3G.

Authors:  Bärbel Schröfelbauer; Tilo Senger; Gerard Manning; Nathaniel R Landau
Journal:  J Virol       Date:  2006-06       Impact factor: 5.103

9.  Dispersed and conserved hydrophobic residues of HIV-1 Vif are essential for CBFβ recruitment and A3G suppression.

Authors:  Xiaohong Zhou; Xue Han; Ke Zhao; Juan Du; Sean L Evans; Hong Wang; Peng Li; Wenwen Zheng; Yajuan Rui; Jian Kang; Xiao-Fang Yu
Journal:  J Virol       Date:  2013-12-18       Impact factor: 5.103

10.  A patch of positively charged amino acids surrounding the human immunodeficiency virus type 1 Vif SLVx4Yx9Y motif influences its interaction with APOBEC3G.

Authors:  Gongying Chen; Zhiwen He; Tao Wang; Rongzhen Xu; Xiao-Fang Yu
Journal:  J Virol       Date:  2009-06-17       Impact factor: 5.103

View more
  19 in total

1.  Feline Immunodeficiency Virus Vif N-Terminal Residues Selectively Counteract Feline APOBEC3s.

Authors:  Qinyong Gu; Zeli Zhang; Lucía Cano Ortiz; Ana Cláudia Franco; Dieter Häussinger; Carsten Münk
Journal:  J Virol       Date:  2016-11-14       Impact factor: 5.103

2.  Evolutionarily conserved pressure for the existence of distinct G2/M cell cycle arrest and A3H inactivation functions in HIV-1 Vif.

Authors:  Ke Zhao; Juan Du; Yajuan Rui; Wenwen Zheng; Jian Kang; Jingwei Hou; Kang Wang; Wenyan Zhang; Viviana A Simon; Xiao-Fang Yu
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

Review 3.  The Road Less Traveled: HIV's Use of Alternative Routes through Cellular Pathways.

Authors:  Ailie Marx; Akram Alian
Journal:  J Virol       Date:  2015-03-11       Impact factor: 5.103

Review 4.  APOBECs and virus restriction.

Authors:  Reuben S Harris; Jaquelin P Dudley
Journal:  Virology       Date:  2015-03-26       Impact factor: 3.616

5.  Core-binding factor subunit beta is not required for non-primate lentiviral Vif-mediated APOBEC3 degradation.

Authors:  Youwei Ai; Dantong Zhu; Cuihui Wang; Chao Su; Jian Ma; Jianzhang Ma; Xiaojun Wang
Journal:  J Virol       Date:  2014-08-13       Impact factor: 5.103

6.  Cellular requirements for bovine immunodeficiency virus Vif-mediated inactivation of bovine APOBEC3 proteins.

Authors:  Wenyan Zhang; Hong Wang; Zhaolong Li; Xin Liu; Guanchen Liu; Reuben S Harris; Xiao-Fang Yu
Journal:  J Virol       Date:  2014-08-20       Impact factor: 5.103

7.  Identification of a Conserved Interface of Human Immunodeficiency Virus Type 1 and Feline Immunodeficiency Virus Vifs with Cullin 5.

Authors:  Qinyong Gu; Zeli Zhang; Christoph G W Gertzen; Dieter Häussinger; Holger Gohlke; Carsten Münk
Journal:  J Virol       Date:  2018-02-26       Impact factor: 5.103

8.  Conserved Interaction of Lentiviral Vif Molecules with HIV-1 Gag and Differential Effects of Species-Specific Vif on Virus Production.

Authors:  Wenwen Zheng; Limian Ling; Zhaolong Li; Hong Wang; Yajuan Rui; Wenying Gao; Shaohua Wang; Xing Su; Wei Wei; Xiao-Fang Yu
Journal:  J Virol       Date:  2017-03-13       Impact factor: 5.103

9.  Lineage-Specific Viral Hijacking of Non-canonical E3 Ubiquitin Ligase Cofactors in the Evolution of Vif Anti-APOBEC3 Activity.

Authors:  Joshua R Kane; David J Stanley; Judd F Hultquist; Jeffrey R Johnson; Nicole Mietrach; Jennifer M Binning; Stefán R Jónsson; Sarah Barelier; Billy W Newton; Tasha L Johnson; Kathleen E Franks-Skiba; Ming Li; William L Brown; Hörður I Gunnarsson; Adalbjorg Adalbjornsdóttir; James S Fraser; Reuben S Harris; Valgerður Andrésdóttir; John D Gross; Nevan J Krogan
Journal:  Cell Rep       Date:  2015-05-14       Impact factor: 9.423

10.  Simian Immunodeficiency Virus Vif and Human APOBEC3B Interactions Resemble Those between HIV-1 Vif and Human APOBEC3G.

Authors:  Jiayi Wang; Nadine M Shaban; Allison M Land; William L Brown; Reuben S Harris
Journal:  J Virol       Date:  2018-05-29       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.